TrialThe Journal of clinical endocrinology and metabolism2016

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.

John P Bilezikian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.